Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:1999); English version prEN ISO 10993-5:2008, Amendment 1
€41.78
Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:1999); English version prEN ISO 10993-9:2008, Amendment 1
Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2007); English version prEN ISO 10993-6:2008, Amendment 1
Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity (ISO 10993-10:2002, including Amd 1:2006); English version prEN ISO 10993-10:2008, Amendment 2
Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2006); English version prEN ISO 10993-11:2008, Amendment 1
Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2007); English version prEN ISO 10993-12:2008, Amendment 1
Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998); English version prEN ISO 10993-13:2008, Amendment 1
Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001); English version prEN ISO 10993-14:2008, Amendment 1
€34.30
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:1997); English version prEN ISO 10993-16:2008, Amendment 1
Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002); English version prEN ISO 10993-17:2008, Amendment 1
Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005); English version prEN ISO 10993-18:2008, Amendment 1
Clinical investigation of medical devices for human subjects - Part 1: General requirements (ISO 14155-1:2003); English version FprEN ISO 14155-1:2009, Amendment 1
Clinical investigation of medical devices for human subjects - Part 2: Clinical investigation plans (ISO 14155-2:2003); English version FprEN ISO 14155-2:2009, Amendment 1
Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2002, including Amd. 1:2006); English version prEN ISO 10993-4:2008, Amendment 2
Nanotechnologies - Endotoxin test on nanomaterial samples for in vitro test systems - Limulus amebocyte lysate (LAL) test (ISO/DIS 29701:2009); German version prEN ISO 29701:2009
€91.03
